International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

Previous Masterclass Agendas

Europe 2019

SESSION 1 – FRIDAY, NOVEMBER 15, 2019
9:00 am – 4:30 pm

Agenda

WELCOME + INTRODUCTION

SESSION TOPICS
Pathogenesis and how it relates to drug
Phenotypes and assessment of psoriasis and psoriatic arthritis
Pustular psoriasis
Comorbidities: Focus on metabolic syndrome and mental health
Optimizing the use of topicals and standard systemics
Optimizing the use of biologics
Challenging cases workshop: An integrated learning experience
Paradoxical reactions to biologics
Comprehensive management of psoriasis

CLOSING COMMENTS

SESSION 2 – SATURDAY, NOVEMBER 16, 2019

9:00 am – 1:00 pm

Agenda

WELCOME + INTRODUCTION

SESSION TOPICS
What did we learn? Reflections on challenging cases workshop from day 1
Challenging cases workshop – presented by delegates
Ambition in psoriasis – Striving for more

CLOSING COMMENTS

India 2019

SESSION 1 – SATURDAY, JUNE 29, 2019
10:00 am – 6:00 pm

Agenda

REGISTRATION, PRE-TEST AND NETWORKING

OPENING COMMENTS
Novartis introduction and overview of program
Welcome and introduction to the International Psoriasis Council

PATHOPHYSIOLOGY OF PSORIASIS – ROLE OF CYTOKINES AND POTENTIAL TARGETS
Evolution of understanding of the cytokines; role of IL-13 and TNFi; differential role of IL-17

OVERVIEW OF PSORIASIS AND COMORBIDITIES
Epidemiology of plaque psoriasis

BREAK

THE CLINICAL SPECTRUM OF PSORIASIS
Screening and assessment, pros and cons and assessment tool, emphasis on PASI

TREATMENT GOALS
Evolution of management from PASI 75 to PASI 100

NON-BIOLOGIC SYSTEMIC AGENTS
Methotrexate, cyclosporine, apremilast and others

LUNCH

BIOLOGICS IN PSORIASIS
Anti-TNFs
IL 12/23
IL-17 and IL-23

MONITORING AND MAINTENANCE OF RESPONSE
Follow up of the patient; lab and clinical parameters

CHALLENGES IN THE LONG TERM MANAGEMENT OF PSORIASIS
Long term efficacy of biologics; reduction/loss of response over a period of time; how to approach such a patient and manag

BREAK

CHALLENGING CASES: IPC MASTERCLASS 1.0 EXPERIENCES

CLOSING COMMENTS

SESSION 1 – SUNDAY, JUNE 30, 2019
9:00 am – 3:00 pm

Agenda

BREAKFAST AND NETWORKING

COMPLEXITIES OF DIAGNOSIS AND TREATMENT – BREAK OUT SESSIONS
Assessment scoring
Treatment failures
Treatment guidelines

CHALLENGING CASES: PRESENTED BY THE FACULTY
Case 1: Palmoplantar
Case 2: Scalp
Case 3: Psoriasis with heart failure

BREAK

NEW TREATMENT PARADIGMS IN THE MANAGEMENT OF PSORIASIS
Role of PDE-4i and P19 as a target

TREATING BEYOND THE SKIN
Focus on psoriatic arthritis: Risk factors, screening and diagnosis

LUNCH

MANAGING COMORBIDITIES AND PSORIASIS IN SPECIAL POPULATIONS – BREAK OUT SESSIONS
Topic 1: Children
Topic 2: Women
Topic 3: Comorbidities

EVALUATION AND CLOSING

Latin America 2021

1ª MÓDU

Masterclass 2021 Programa: Actualizaciones en Psoriasis

Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm

Agenda

Introducciones
Claudia de la Cruz

Actualizaciones en Fisiopatología
Matías Maskin

Global Psoriasis Atlas (GPA) y Epidemiologia en LATAM
Chris Griffiths

Severidad en Psoriasis: Categorías
Peter van de Kerkhof

Metas de tratamiento, Target to treat
Cristina Echeverría

Discusión

Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Matías Maskin, Peter van de Kerkhof

2º MÓDULO

Masterclass 2021 Programa: Actualizaciones en Psoriasis

Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm

Agenda

Actualizaciones Clínicas
Enrique Rivas

Actualizaciones en Psoriasis Ungueal y Pustulosa
César González

Actualizaciones en Comorbilidades; manifestaciones extracutáneas
Ron Vender

Actualizaciones en Artritis Psoriática
Alice Gottlieb

Discusión

Presentación de casos clínicos
 Claudia de la Cruz, Cristina Echeverría, César González, Angela Londoño, Enrique Rivas, Peter van de Kerkhof

3º MÓDULO

Masterclass 2021 Programa: Actualizaciones en Psoriasis

Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm

Agenda

Actualización en Terapias Convencionales: Tópicos
Matías Maskin

Actualización en Terapias Sistémicas Convencionales: Metotrexato (oral, inyectable), qué hay de nuevo
Angela Londoño

Actualización en Terapias Sistémicas Convencionales: Fototerapia (PUVA; NBUVB; EXCIMER), qué hay de nuevo
César González

Nuevas Terapias Orales: Apremilast, inhibidores JAK, Tyk2 
Cristina Echeverría

Discusión

Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Angela Londoño, Matías Maskin, Peter van de Kerkhof

4º MÓDULO

Masterclass 2021 Programa: Actualizaciones en Psoriasis

Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm

Agenda

Actualización en Terapias Biológicas: bloqueadores Anti TNF alfa 
Claudia de la Cruz

Actualización en Terapias Biológicas: Biosimilares
Cristina Echeverría

Actualización en Terapias Biológicas: Inhibidores de IL17
Enrique Rivas

Inhibidores de Il12 y 23
Matías Maskin

Discusión

Presentación de casos clínicos
Claudia de la Cruz, Cristina Echeverría, César González, Angela Londoño, Matías Maskin, Enrique Rivas, Peter van de Kerkhof

5º MÓDULO

Masterclass 2021 Programa: Actualizaciones en Psoriasis

Timezones:
Guatemala City/San Jose: 12:00 pm – 2:00 pm
Bogota/Mexico City: 1:00 pm – 3:00 pm
Santiago/Asunción: 2:00 pm – 4:00 pm
Buenos Aires/São Paulo: 3:00 pm – 5:00 pm

Agenda

Actualización en Terapias Biológicas: lo nuevo (inhibidores de IL36)
César González

Psoriasis y salud mental
Karina Malvido 

Psoriasis y Covid I: Cómo afecta la pandemia a nuestros pacientes
Claudia de la Cruz

Psoriasis y Covid II: VACUNAS en latam
Juan Bravo Ojeda

Discusión
Mesa redonda: Cómo escoger el Tratamiento adecuado para mi paciente
Claudia de la Cruz, Cristina Echeverría, César González, Karina Malvido, Juan Bravo Ojeda 

Middle East and North Africa 2021

DAY 1 – FRIDAY, JANUARY 15, 2021

Epidemiology, Pathogenesis and Comorbidities

Timezones:

  • Nouakchott: 11:00 am – 1:00 pm
  • Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
  • Rabat/Tunis: 12:00 – 2:00 pm
  • Kuwait City: 2:00 – 4:00 pm
  • Tehran: 2:30 – 4:30 pm

Agenda

OPENING COMMENTS
Mahira Hamdy El Sayed, MSc, MD

The Global Psoriasis Atlas: Epidemiology and access
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci

Pathophysiology of psoriasis and implications for treatment
Mohamed El-Komy, MD

CLINICAL PRESENTATIONS OF PSORIASIS AS SYSTEMIC DISEASE

Case 1: Psoriatic Arthritis
Ahmed Nassar, Ain Shams University

Case 2: Cardiovascular
Miriam Samir, Ain Shams University

Case 3: Obesity with diabetes
Aya AlOrbani, Cairo University

 

CLOSING

DAY 2 – FRIDAY, JANUARY 22, 2021

Phenotypes, Disease Assessment and Treatment Targets

Timezones:

  • Nouakchott: 11:00 am – 1:00 pm
  • Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
  • Rabat/Tunis: 12:00 – 2:00 pm
  • Kuwait City: 2:00 – 4:00 pm
  • Tehran: 2:30 – 4:30 pm

Agenda

Every patient has his own psoriasis
Peter van de Kerkhof, MD, PhD

Erythroderma – Case + Panel discussion
Mahira Hamdy El Sayed, MSc, MD

Pustular psoriasis
Nejib Doss, MD

Pediatric psoriasis
Mahira Hamdy El Sayed, MSc, MD

Audience Q & A
Faculty

DAY 3 – FRIDAY, JANUARY 29, 2021

Treatment Options and Management

Timezones:

  • Nouakchott: 11:00 am – 1:00 pm
  • Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
  • Rabat/Tunis: 12:00 – 2:00 pm
  • Kuwait City: 2:00 – 4:00 pm
  • Tehran: 2:30 – 4:30 pm

Agenda

How to treat patients with mild disease
Mahira Hamdy El Sayed, MSc, MD

What to do when topicals are not appropriate anymore
Mohamed El-Komy, MD

How to treat patients with severe psoriasis of the skin
Peter van de Kerkhof, MD, PhD

How to treat psoriasis with comorbidities
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci

Audience Q & A
Faculty

 

DAY 4 – FRIDAY, FEBRUARY 5, 2021

Specific Areas and Specific Situations

Timezones:

  • Nouakchott: 11:00 am – 1:00 pm
  • Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
  • Rabat/Tunis: 12:00 – 2:00 pm
  • Kuwait City: 2:00 – 4:00 pm
  • Tehran: 2:30 – 4:30 pm

Agenda

Discussion: Biosimilars
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci, moderator
Mahira Hamdy El Sayed, MSc, MD, Omid Zargari, MD, FAAD, panelists

Discussion: Psoriasis in women
Peter van de Kerkhof, MD, PhD, moderator
Mahira Hamdy El Sayed, MSc, MD, panelist

Nails and Scalp
Mohamed El-Komy, MD

Pruritis + other symptoms
Nejib Doss, MD

Audience Q & A
Faculty

DAY 5 – FRIDAY, FEBRUARY 12, 2021

Challenging Cases

Timezones:

  • Nouakchott: 11:00 am – 1:00 pm
  • Cairo/Khartoum/Tripoli: 1:00 – 3:00 pm
  • Rabat/Tunis: 12:00 – 2:00 pm
  • Kuwait City: 2:00 – 4:00 pm
  • Tehran: 2:30 – 4:30 pm

Agenda

Challenging cases by attendees
Asma Ghanem Bashir, Libya
Moneer Omran Bugrein, Libya
Sahar Dadkhahfar, Iran
Manal Elmubarak, Sudan
Mostafa Khalaf, Egypt
Alia Ramadan, Egypt

The future of psoriasis
Peter van de Kerkhof, MD, PhD

Personalized medicine
Christopher EM Griffiths, OBE, MD, FRCP, FMedSci

Key learnings and program closing
Mahira Hamdy El Sayed, MSc, MD, moderator